SEARCH

SEARCH BY CITATION

References

  • 1
    Cassidy JT & Petty RE. Textbook of pediatric rheumatology, 3rd edn. Philadelphia: W.B. Saunders Co., 1995: 384 8.
  • 2
    Knight JF. The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch–Schönlein purpura. Pediatr Nephrol 1990; 4:533 41.
  • 3
    Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch–Schönlein syndrome. Lancet 1973; 1:892 3.
  • 4
    Jennette JC, Falk RJ, Andrassy K et al. Nomenclature system of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37:187 92.
  • 5
    Jennette JC & Falk RJ. Small-vessel vasculitis. N Eng J Med 1997; 337:1512 23.
  • 6
    Sneller MC & Fauci AS. Pathogenesis of vasculitis syndromes. Adv Rheumatol 1997; 81:221 42.
  • 7
    Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985; 11:591 609.
  • 8
    Albert SO, Josep OR, Francesc MF et al. IgA anticardiolipin antibodies—relation with other antiphospholipid antibodies and clinical significance. Thromb Haemost 1998; 79:282 5.
  • 9
    Merkel PA, Chang Y, Pierangeli SS et al. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996; 101:576 83.
  • 10
    Pierangeli SS. Induction of thrombosis in a mouse model by IgG, IgM, and IgA immunoglobulins from patients with the antiphospholipid. Thromb Haemost 1995; 74:1361 7.
  • 11
    Wilson WA, Faghiriz Z, Taheri F, Gharavi AE. Significance of IgA antiphospholipid antibodies. Lupus 1998; 7 (Suppl. 2):110 3.
  • 12
    Monila JF, Sergio GU, Molina J et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol 1997; 24:291 6.
  • 13
    Frampton G, Winer JB, Cameron JS et al. Severe Guillain–Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 1988; 19:133 9.
  • 14
    Gollier D, Enzenauer R, Santos M et al. IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis. Arthritis Rheum 1992; 35 (Suppl. 9):346.
  • 15
    Wilson WA, Morgan Ost C, Barton EN et al. IgA antiphospholipid antibodies in HTLV-I associated tropical spastic paraparesis. Lupus 1995; 4:138 41.
  • 16
    Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41:8 15.
  • 17
    Burden AD, Gibson IW, Rodger RSC, Tillman DM. IgA anticardiolipin antibodies associated with Henoch–Schönlein purpura. J Am Acad Dermatol 1994; 31:857 60.
  • 18
    Burden AD, Tillman DM, Foley P, Holme E. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1996; 35:411 5.
  • 19
    Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989; 170:1039 44.
  • 20
    Van Valsselaer P, Punnonen J, De Vries JE. Transforming growth factor beta. Immunology 1998; 9:215 20.
  • 21
    Mills JA, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Henoch–Schönlein purpura. Arthritis Rheum 1990; 33:1114 21.
  • 22
    Harris EN, Gharavi AE, Patel SP, Hughes GVR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68:215 22.
  • 23
    Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol 1976; 6:183 228.
  • 24
    Schulman ST, Barratt TM, Soothill JF. Immunoconglutinin and complement studies in congenital nephrotic syndrome and Henoch–Schönlein purpura in children. Arch Dis Child 1971; 46:838 41.
  • 25
    Garcia-Fuentes M, Martin A, Chantler C, Williams DG. Serum complement components in Henoch–Schönlein purpura. Arch Dis Child 1978; 53:417 9.
  • 26
    Petersen S, Taainig E, Soderstrom T, Pilgaard B, Tranebjaerg L, Christensen T, Nielsen HE. Immunoglobulin and complement studies in children with Schönlein–Henoch syndrome and other vasculitic diseases. Acta Paediatr Scand 1991; 80:1037 43.
  • 27
    Casanueva B, Rodrigus-Valverde V, Merion J, Arias M, Garcia-Fuentes M. Increased IgA producing cells in the blood of patients with Henoch–Schönlein purpura. Arthritis Rheum 1983; 26:854 60.
  • 28
    Trygstad CW & Stiehm ER. Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics 1971; 47:1023 8.
  • 29
    Kondo N, Kasahara K, Shinoda S, Orii T. Accelerated expression of secreted a-chain gene in anaphylactoid purpura. J Clin Immunol 1992; 12:193 6.
  • 30
    Beale MG, Nash GS, Bertovich MJ, MacDermott RP. Evidence of enhanced immunoglobulin synthesis and defective immune regulation in Henoch–Schönlein purpura. Contr Nephrol 1983; 35:46 60.
  • 31
    Heimstra PS, Biewenga J, Gorter A. Activation of complement by human serum IgA, secretory IgA and IgA1 fragment. Mol Immunol 1988; 26:527 33.
  • 32
    Lin SC, Tsai MJ, Huang MT, Wu KH, Wang LH, Chiang BL. Immunological studies of children with anaphylactoid purpura. Acta Paed Sin 1998; 39:247 52.
  • 33
    Musumeci S, Sciotto A, Rosalba A, Volti SL, Mollica F. Lymphocyte subpopulations in anaphylactoid purpura. Arch Dis Child 1980; 55:541 3.
  • 34
    Sun XC, Chen MY, Cheng AS, Xu DL. Immunologic changes in children with Henoch–Schönlein purpura in the acute phase. Chin Med J 1989; 102:533 6.
  • 35
    Senger DPS, Acharya CD, Wolfish NM. HLA specificities, lymphocytes subsets, and mitogenic response in Henoch–Schönlein purpura nephritis. Int J Pediatr Nephrol 1984; 5:197 200.
  • 36
    Casali P & Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10:364 8.
  • 37
    Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998; 25:1730 6.
  • 38
    Ordi J, Selva A, Monegal F et al. Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis. J Rheumatol 1993; 20:1321 4.
  • 39
    Koike T. Anticardiolipin antibodies and β2-glycoprotein I . Clin Immunol Immunopathol 1994; 72:187 92.
  • 40
    Saulsburg FT. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch–Schönlein purpura. Arthritis Rheum 1992; 35:1377 80.
  • 41
    Ronda N, Esnault VL, Layward L et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch–Schönlein purpura. Clin Exp Immunol 1994; 95:49 55.
  • 42
    Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335 43.
  • 43
    Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW. Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Immunol 1992; 99:1 7.
  • 44
    Letterio JJ & Roberts AB. TGF-β: a critical modulator of immune cell function. Clin Immunol Immunopathol 1997; 84:244 50.
  • 45
    Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18:61 64.
  • 46
    Jung T, Schauer U, Heusser C, Neumann C, Reiger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197 207.
  • 47
    Farely TA, Gillespei S, Rasoulpour M et al. Epidemiology of a cluster of Henoch–Schönlein purpura. Am J Dis Child 1989; 143:798 883.
  • 48
    Atkinson SR & Barker DJ. Seasonal distribution of Henoch–Schönlein purpura. Br J Prev Soc Med 1976; 30:22 25.
  • 49
    Al-Sheyyab M, El-Shanti H, Ajlouni S et al. Henoch–Schönlein purpura; clinical experience and contemplations on a streptococcal association. J Trop Paediatr 1996; 42:200 3.
  • 50
    Steare SE, Wiselka MJ, Kurinczuk JJ, Nicholson KG. Mycoplasma pneumoniae infection associated with Henoch–Schönlein purpura . J Infection 1988; 16:305 7.
  • 51
    Pedersen FK & Petersen EA. Varicella followed by glomerulonephritis. Treatment with corticosteroid and azathioprine resulting in recurrence of varicella. Acta Paediatr Scand 1975; 64:886 90.
  • 52
    Oner A, Demircin G, Tinaztepe K, Akinci A, Tezic T. Henoch–Schönlein purpura nephritis associated with subacute thyroiditis. Turkish J Pediatr 1996; 38:131 553.